Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Healthequity (HQY) Restructuring Costs (2019 - 2026)

Healthequity has reported Restructuring Costs over the past 8 years, most recently at $1.3 million for Q1 2026.

  • For Q1 2026, Restructuring Costs fell 39.21% year-over-year to $1.3 million; the TTM value through Jan 2026 reached $5.0 million, down 87.61%, while the annual FY2026 figure was $5.0 million, 87.61% down from the prior year.
  • Restructuring Costs for Q1 2026 was $1.3 million at Healthequity, up from $1.2 million in the prior quarter.
  • Over five years, Restructuring Costs peaked at $34.4 million in Q4 2024 and troughed at $1.2 million in Q4 2025.
  • A 5-year average of $6.5 million and a median of $2.3 million in 2024 define the central range for Restructuring Costs.
  • Biggest five-year swings in Restructuring Costs: surged 1197.06% in 2024 and later tumbled 96.63% in 2025.
  • Year by year, Restructuring Costs stood at $6.5 million in 2022, then plummeted by 59.21% to $2.7 million in 2023, then surged by 1197.06% to $34.4 million in 2024, then tumbled by 96.63% to $1.2 million in 2025, then rose by 14.24% to $1.3 million in 2026.
  • Business Quant data shows Restructuring Costs for HQY at $1.3 million in Q1 2026, $1.2 million in Q4 2025, and $1.3 million in Q3 2025.